{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:11:41Z","timestamp":1788610301605,"version":"build-2803163510"},"reference-count":21,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Lille Catholic Hospitals"},{"name":"Horizon Pharmaceutical"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,10,10]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine factors influencing the kinetics of monosodium urate (MSU) crystal dissolution measured with dual-energy computed tomography (DECT) during follow-up of patients with gout.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with a diagnosis of gout with baseline knees and feet DECT scans exhibiting MSU crystal volumes \u22650.1\u2009cm<jats:sup>3<\/jats:sup> and at least one follow-up DECT were included. Spearman\u2019s correlation coefficient was used to search for association between change from baseline MSU crystal volume at 6, 12, 18 and 24 months and serum urate (SU) level. Associations between percentage change from the baseline volume of MSU crystal deposits and explanatory variables were assessed using linear mixed models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sixty-two patients (age 67.3\u00b112.8 years; 53 (85%) males) cumulating 104 follow-up DECT scans were included. Overall, SU target levels (&lt;6.0\u2009and &lt;5.0\u2009mg\/dL) were achieved by 48 (77%) and 36 (58%) patients, respectively. There was a good correlation (<jats:italic>r<\/jats:italic>=0.66; p&lt;0.0001) observed between SU level and percentage change in MSU crystal volume. The median decrease from baseline MSU crystal volume was greater in patients reaching the &lt;5.0\u2009mg\/dL SU target than in those reaching \u22655.0\u2009SU &lt;6.0\u2009mg\/dL: \u221285% (95% CI: \u221294% to \u221272%) versus \u221240% (\u221257% to \u221222%; p&lt;0.05) at 12 months. In multivariable analysis, time (in days) with a multilevel coefficient of \u22120.06 (95%\u2009CI: \u22120.08 to \u22120.03, p&lt;0.001), hypertension (coefficient: 41.87, 95%\u2009CI: 16.38 to 67.18, p&lt;0.01) and SU level &lt;5.0\u2009mg\/dL (coefficient: \u221239.46, 95%\u2009CI: \u221270.93 to \u22128.34, p=0.02) were the only variables significantly associated with MSU crystal volume change.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In patients with DECT-measured MSU crystal deposition, reaching the &lt;5.0\u2009mg\/dL SU target provides more extensive and rapid crystal dissolution than reaching the &lt;6.0\u2009mg\/dL SU target.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003725","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T11:51:44Z","timestamp":1699444304000},"page":"e003725","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout"],"prefix":"10.1136","volume":"9","author":[{"given":"Victor","family":"Laurent","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jauffret","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Pacaud","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ducoulombier","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Legrand","sequence":"additional","affiliation":[{"name":"Department of Radiology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Verdun","sequence":"additional","affiliation":[{"name":"Research Department, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Norberciak","sequence":"additional","affiliation":[{"name":"Research Department, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Budzik","sequence":"additional","affiliation":[{"name":"Department of Radiology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-826X","authenticated-orcid":false,"given":"Tristan","family":"Pascart","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Universit\u00e9 Catholique de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"2025090312512471000_9.4.e003725.1","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312512471000_9.4.e003725.2","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1714-9","article-title":"Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study: MSU burden and risk of gout flare","volume":"20","author":"Pascart","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025090312512471000_9.4.e003725.3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jbspin.2020.05.002","article-title":"2020 recommendations from the French society of rheumatology for the management of gout: urate-lowering therapy","volume":"87","author":"Pascart","year":"2020","journal-title":"Joint Bone Spine"},{"key":"2025090312512471000_9.4.e003725.4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/gucdd1010005","article-title":"Year in review: gout clinical research","volume":"1","author":"Urquiaga","year":"2023","journal-title":"GUCDD"},{"key":"2025090312512471000_9.4.e003725.5","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-0890-1","article-title":"Utility of ultrasound and dual energy CT in crystal disease diagnosis and management","volume":"22","author":"Filippou","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2025090312512471000_9.4.e003725.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208237"},{"key":"2025090312512471000_9.4.e003725.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215315"},{"key":"2025090312512471000_9.4.e003725.8","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1093\/rheumatology\/keaa920","article-title":"Crystal deposition measured with dual-energy computed tomography: association with mortality and cardiovascular risks in gout","volume":"60","author":"Marty-An\u00e9","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312512471000_9.4.e003725.9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.40929","article-title":"Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual-energy computed tomography imaging study within a randomized, controlled trial","volume":"71","author":"Dalbeth","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090312512471000_9.4.e003725.10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.41063","article-title":"Effects of conventional uric acid-lowering therapy on monosodium urate crystal deposits","volume":"72","author":"Ellmann","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025090312512471000_9.4.e003725.11","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/acr.25084","article-title":"Changes in tophus composition during urate-lowering therapy: a dual-energy computed tomography study","volume":"75","author":"Chen","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"SI","key":"2025090312512471000_9.4.e003725.12","doi-asserted-by":"crossref","first-page":"SI81","DOI":"10.1093\/rheumatology\/keab533","article-title":"Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-gout longitudinal study","volume":"61","author":"Uhlig","year":"2022","journal-title":"Rheumatology"},{"key":"2025090312512471000_9.4.e003725.13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051295","article-title":"Association of specific comorbidities with monosodium urate crystal deposition in urate-lowering therapy-naive gout patients: a cross-sectional dual-energy computed tomography study","volume":"9","author":"Pascart","year":"2020","journal-title":"J Clin Med"},{"key":"2025090312512471000_9.4.e003725.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212046"},{"key":"2025090312512471000_9.4.e003725.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32158-5"},{"key":"2025090312512471000_9.4.e003725.16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.42055","article-title":"Intensive serum urate lowering with oral urate-lowering therapy for erosive gout: a randomized double-blind controlled trial","volume":"74","author":"Dalbeth","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025090312512471000_9.4.e003725.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.10511"},{"key":"2025090312512471000_9.4.e003725.18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025090312512471000_9.4.e003725.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"2025090312512471000_9.4.e003725.20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/gucdd1010002","article-title":"The 2022 NICE guideline for the diagnosis and management of gout","volume":"1","author":"Dahanayake","year":"2023","journal-title":"GUCDD"},{"key":"2025090312512471000_9.4.e003725.21","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1381-2","article-title":"Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study","volume":"19","author":"Pascart","year":"2017","journal-title":"Arthritis Res Ther"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:51:33Z","timestamp":1756929093000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,8]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/rmdopen-2023-003725"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003725","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}